Concepedia

Michael G. Cordingley

MG

Statistics

Publications

55

Citations

5.2K

H-Index

37

Active since

1981

Affiliations

Boehringer Ingelheim (Canada)(Current)

Boehringer Ingelheim (Egypt)

Boehringer Ingelheim (Germany)

National Cancer Institute

Bristol-Myers Squibb (United States)

Michael G. Cordingley is an author at Boehringer Ingelheim (Canada) specializing in molecular virology, life sciences, and virology.

Publications per year

1981–2014

55

Publications

55

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Daniel Lamarre, Paul C. Anderson, Murray D. Bailey et al. · Nature · 2003 · 913 citations

, , +15

Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo

Michael G. Cordingley, Anna T. Riegel, Gordon L. Hager · Cell · 1987 · 447 citations

, , +17

Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter.

Trevor Archer, Michael G. Cordingley, Ronald G. Wolford et al. · Molecular and Cellular Biology · 1991 · 363 citations · Full text

, , +17

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

James J. Crute, Christine A. Grygon, Karl D. Hargrave et al. · Nature Medicine · 2002 · 231 citations

, , +13

Substrate requirements of human rhinovirus 3C protease for peptide cleavage in vitro.

Michael G. Cordingley, P L Callahan, Vinod Sardana et al. · Journal of Biological Chemistry · 1990 · 209 citations · Full text

, , +16

1–5 of 55